• 1. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Glycine, N-[(4-aminophenyl)sulfonyl]-, 1,1-dimethylethyl ester (CAS No. 188005-65-4): A Comprehensive Overview

Glycine, N-[(4-aminophenyl)sulfonyl]-, 1,1-dimethylethyl ester, identified by its CAS number 188005-65-4, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and development. This compound belongs to a class of derivatives that exhibit unique chemical properties, making it a valuable candidate for various applications in medicinal chemistry and biotechnology.

The molecular structure of Glycine, N-[(4-aminophenyl)sulfonyl]-, 1,1-dimethylethyl ester consists of a glycine backbone modified with a sulfonyl group attached to a phenyl ring, which is further substituted with an amine group. The presence of the tert-butyl ester group enhances its stability and solubility, making it more amenable for synthetic applications. This structural configuration imparts distinct reactivity patterns that are exploited in the design of novel therapeutic agents.

In recent years, there has been growing interest in exploring the pharmacological potential of Glycine, N-[(4-aminophenyl)sulfonyl]-, 1,1-dimethylethyl ester due to its ability to interact with biological targets in unique ways. Studies have indicated that this compound may exhibit inhibitory effects on certain enzymes and receptors, which are implicated in various diseases. For instance, preliminary research suggests that it could interfere with the activity of proteases involved in inflammation and cancer progression.

The synthesis of Glycine, N-[(4-aminophenyl)sulfonyl]-, 1,1-dimethylethyl ester involves a multi-step process that requires precise control over reaction conditions to ensure high yield and purity. The key steps include the formation of the sulfonyl group followed by the introduction of the tert-butyl ester. Advanced synthetic methodologies, such as transition metal-catalyzed cross-coupling reactions, have been employed to optimize the process and improve efficiency.

One of the most compelling aspects of Glycine, N-[(4-aminophenyl)sulfonyl]-, 1,1-dimethylethyl ester is its potential as a building block for more complex molecules. Its modular structure allows for facile modifications at multiple positions, enabling chemists to tailor its properties for specific applications. This flexibility has made it a popular choice for drug discovery programs aimed at developing novel small-molecule inhibitors.

Recent advancements in computational chemistry have further enhanced the understanding of how Glycine, N-[(4-aminophenyl)sulfonyl]-, 1,1-dimethylethyl ester interacts with biological targets. Molecular docking studies have revealed that it can bind to pockets on enzymes and receptors with high affinity. These findings provide valuable insights into its mechanism of action and guide the design of more potent derivatives.

The pharmacokinetic profile of Glycine, N-[(4-aminophenyl)sulfonyl]-, 1,1-dimethylethyl ester is another area of active investigation. Initial studies suggest that it exhibits moderate oral bioavailability and rapid metabolic clearance. Understanding these properties is crucial for optimizing dosing regimens and minimizing potential side effects. Further research is needed to elucidate its metabolic pathways and identify any metabolites that may contribute to its therapeutic effects.

In conclusion, Glycine, N-[(4-aminophenyl)sulfonyl]-, 1,1-dimethylethyl ester (CAS No. 188005-65-4) represents a promising compound with diverse applications in pharmaceutical research. Its unique structural features and biological activity make it an attractive candidate for further development. As our understanding of its properties continues to grow, so too will its potential role in addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)